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Abstract
Background: The combined effects of the patient’s and the family’s preferences for death at home have in
determining the actual site of death has not been fully investigated. We explored this issue on patients who had
been receiving end-of-life care from Visiting Nurse Stations (VNS). In Japan, it has been the government’s policy to
promote end-of-life care at home by expanding the use of VNS services.
Methods: A retrospective national survey of a random sample of 2,000 out of the 5,224 VNS was made in January
2005. Questionnaires were mailed to VNS asking the respondents to fill in the questionnaire for each patient who
had died either at home or at the hospital from July to December of 2004. Logistic regression analysis was
respectively carried out to examine the factors related to dying at home for cancer and non-cancer patients.
Results: We obtained valid responses from 1,016 VNS (50.8%). The total number of patients who had died in the
selected period was 4,175 (cancer: 1,664; non-cancer: 2,511). Compared to cancer patients, non-cancer patients
were older and had more impairment in activities of daily living (ADL) and cognitive performance, and a longer
duration of care. The factor having the greatest impact for dying at home was that of both the patient and the
family expressing such preferences [cancer: OR (95% CI) = 57.00 (38.79-83.76); non-cancer: OR (95% CI) = 12.33
(9.51-15.99)]. The Odds ratio was greater compared with cases in which only the family had expressed such a
preference and in which only the patient had expressed such a preference. ADL or cognitive impairment and the
fact that their physician was based at a clinic, and not at a hospital, had modest effects on dying at home.
Conclusions: Dying at home was more likely when both the patient and the family had expressed such
preferences, than when the patient alone or the family alone had done so, in both cancer and non-cancer
patients. Health care professionals should try to elicit the patient’s and family’s preferences on where they would
wish to die, following which they should then take appropriate measures to achieve this outcome.
Background
How end-of-life care should appropriately be provided
has been a major policy issue [1-3]. Many factors have
to be considered in deciding what is “appropriate”,
including the patient’s condition and preferences [4-6],
the situation of the family [6,7], and the services avail-
able [8-10]. If the patient prefers to die at home, that
should be respected as much as possible, but the patient
might not be in a position to express his or her wish,
and the family’s preference and capacity to provide care
must also be taken into consideration [11-13].
Epidemiological surveys using death certificates have
shown that the older the patient, the more likely he or
she is to die in a non-hospital setting (i.e. nursing home
or own home) [14-16]. For patients with activities of
daily living (ADL) and cognitive problems in institu-
tional settings, the preferences of the family or the atti-
tude of the nursing home directors may take precedence
in determining the place of death [17-19]. For cancer
patients, after reviewing the literature focusing on 17
factors associated with dying at home, Gomes concluded
that the patient’s low functional status, the patient’s * Correspondence: ikezaki@sc.itc.keio.ac.jp
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support were significant factors [20].
We decided to focus on the combined effects of the
patient’s and the family’s preferences in determining the
actual site of death in cancer and non-cancer patients.
Both have been noted as being independently related
to the site of death [6,21,22], but how they affect each
other has only been confirmed by an interview survey
[23], and has yet to be statistically analysed.
As subjects, we chose patients who had been receiving
professional nursing services in their homes. The reason
for doing so is because the Japanese government has
announced a policy initiative to promote end-of-life care
at home by expanding Visiting Nurse Stations (VNS)
services [24,25]. However, visiting nurses have not
received formal specialized training in end-of-life care
so that whether they could contribute in realizing the
policy goal of increasing the proportion of deaths at
home has yet to be investigated.
The other reason why we chose to focus on patients
served by VNS was because access to death certificate
data is denied to researchers in Japan [26]. Thus, infor-
mation is only available through either the providers’
records, or through questionnaires sent to family mem-
bers of the deceased patients by providers.
Studies have been made using data from VNS but they
have been conducted either prior to the implementation
of the long-term care insurance (LTCI) [27], or were
limited in their scope to cancer patients after its imple-
mentation [5,21]. The implementation of the LTCI may
have had a significant impact on the possibility of dying
at home because it has greatly expanded home and
community services, and by doing so, has decreased the
burden to the family care giver [6,11].
In Japan, the proportion dying at home has declined to
12.3% of all deaths, while the proportion dying in hospitals
had increased to 79.4% [28], which is high compared with
34% in the Netherlands and 58% in England [29]. Develop-
ing palliative care services would have been obvious solu-
tion but the limited resources have been mostly targeted
on palliative inpatient care units [30,31]. These units may
only admit patients diagnosed with either cancer or AIDS
by health insurance regulations [32], and although their
number has increased, the percentage of deaths from can-
cer that occur in these units is still only 6% [33].
The aims of this study are as follows:
￿ To describe and compare cancer patients and non-
cancer patients who had been receiving VNS service
prior to their death at home or in hospital
￿ To analyse the factors related to dying at home in
the two groups, and focusing on the combined
effects of the patient’s and the family’s preferences
Methods
Design
This was designed as a retrospective case-control study
of patients served by VNS. Of the patients who had died
during the period observed, those who had died at
home were regarded as the case group, and those who
had died in a hospital within four weeks after admission
to the hospital were regarded as the control group.
Sample and participants
A tt h et i m eo fo u rs t u d y ,t h e r ew e r e5 , 2 2 4V N S[ 3 4 ] .
Unlike other countries where visiting nurses focus on
post-acute care, VNS were first established in 1992 to
provide medical supervision, personal hygiene assistance
and guidance to families on care giving for bed bound
patients on a long-term basis [35]. When the public
long-term care insurance (LTCI) was established in
2000, most of their services were transferred from health
insurance to the LTCI. However, the service for patients
who required more intensive care, such as those with
amyotrophic lateral sclerosis and terminal cancer,
remained with health insurance. Almost all VNS nurses
provide services for both groups of patients, each having
her assigned patients. At the time of our survey, the
total number of those receiving community LTCI ser-
vices and health insurance financed VNS services was
2.14 million, of which 0.28 million (13%) were using
VNS services [34]. Among those receiving VNS services,
it has been reported that three in one was bedbound,
and four in one required professional nursing services
such as suction, drip infusion and pressure ulcer care
[36]. A national report estimated that, among those
dying at home, 17% had been receiving VNS services
[34].
Our sample was recruited in the following way. First, we
selected VNS by random sampling. A list of VNS to be
surveyed was made from a national electronic database of
5,224 VNS, from which we selected 2,000 stratified by
postal code at regular intervals so as to derive a geographi-
cally representative sample (sampling rate: 38.3%). The
number of VNS selected was set, with an expected
response rate of 50%, so that 1,000 valid responses could
be obtained. The number 1,000 has been regarded as
being the goal to obtain a nationally representative sample
in Japan and for social surveys in general [37].
Next, questionnaires on patients who had died from
July to December of 2004 were sent to the VNS
selected. This period of six months was chosen after
taking into consideration the burden to the VNS.
According to Fukui [21], the average number of deaths
per VNS was 0.7 deaths per month so that this would
require filling out an average of four forms per VNS.
Patients under twenty years old were excluded because
Ikezaki and Ikegami BMC Palliative Care 2011, 10:3
http://www.biomedcentral.com/1472-684X/10/3
Page 2 of 11they differed in terms of disease types, clinical care and
family support [38].
Procedure
Questionnaires were sent to 2,000 VNS in January, 2005.
A cover letter explained the objective of the study, with
a note stating that the anonymity of the patients and
nurses would be strictly preserved. Consent to partici-
pate was indicated by the return of the questionnaire by
mail.
The VNS nurse in charge of each patient completed
the questionnaires, which consisted of one page each for
every patient meeting the criteria based on the informa-
tion in their nursing records [Additional file 1]. All data
were returned from the VNS in one lot. Each returned
questionnaire was assigned an ID number by two per-
sons other than the authors.
Ethical consideration
In view of the audit nature of the research, a formal
ethics proposal was not required at the time of the
study in Japan so that consent was not requested from
the bereaved families [39]. The cover letter clearly stated
that the decision to participate in our study was a
v o l u n t a r i l yo n et ob em a d eb yt h ed i r e c t o ro ft h eV N S .
No identifying information was collected or stored. All
data were aggregated for analysis.
Measure
We selected variables that would be uniformly available
in the VNS records and have been cited as relating to
the site of death in two review articles [7,20]. ADL func-
tion was evaluated based on a 4 level score of their
mobility: almost independent (J), home bound (A), chair
bound (B), completely bed bound (C) [40]. Cognitive
function was evaluated based on a 6 level score: comple-
tely independent, almost independent having no pro-
blem in daily life (I), occasional monitoring (II), daily
c a r ea s s i s t a n c e( I I I ) ,c o n t i nuous daily care assistance
(IV), special professional care (M) [40]. The ADL and
cognitive status must be recorded in the physician’s
order form, which is then transcribed into VNS records.
These orders are given in the beginning of every calen-
der month, based on reports from the VNS to the doc-
tor. Thus, the condition recorded is that at the
beginning of the month when death occurred or when
hospitalized, except when the VNS services were pro-
vided for less than one month, in which case, the condi-
tion when the services had commenced was coded. We
dichotomized the ADL function into bed bound (C) and
others [5,21] because, in the former, patients and
families tend to prefer maximal comfort, rather than
prolonged survival, to which providers should adhere
[41]. We also dichotomized cognitive function into that
of the two severest levels, which would correspond to a
CPS (Cognitive Performance Scale) level of 5 or more,
and the rest [19], because, although it is difficult to pre-
dict death, intensive treatment has been shown not to
prolong life in advanced dementia so that patients at
this stage would be more likely to die at home [12,42].
For the cause of death, the VNS nurse was instructed
to choose from the following: cancer, heart diseases,
pneumonia, cerebrovascular diseases, old age and others.
All causes other than “cancer” were grouped into “non-
cancer” in the analysis. Other data gathered were vari-
ables related to the amount of family support, presence
of family caregiver [6,21], the date when the VNS ser-
vice had commenced, the use of VNS 24-hour emer-
gency service [43], where the physician was based [9],
and the use of home help services.
For the preference on the place of death, we asked
where the patient and the family had respectively pre-
ferred to die: home, hospital, or unknown. “Unknown”
could mean either that the patient and/or the family did
have preferences which were not known by the VNS
nurse, or the patient and/or the family did not have any
explicit preferences [44]. The preferences were those of
the latest recorded.
Statistical analysis
Differences in the characteristics of cancer and non-can-
cer patients were analysed.
First, bivariate analyses were performed with chi-
square test for nominal variables, the Mann-Whitney U
test [45] for ordered variables and Student’s t-test for
continuous variables. Second, a logistic regression analy-
sis of the place of death was made for cancer and non-
cancer patients respectively. Patients having missing
values were excluded when making the bivariate analy-
sis. Third, a multivariate logistic regression [46], in
which independent variables with p-values < 0.1 in the
bivariate analysis were entered with age and gender as
controlling factors, was made for the same dependent
variable. Patients having missing values in ADL and cog-
nition were excluded in the multiple logistic analysis.
For the multiple logistic regression analysis, we com-
bined ADL and cognitive function into 4 categories:
severely impaired in both ADL and cognition, severely
impaired in ADL but not severely impaired in cognition,
not severely impaired in ADL but severely impaired in
cognition, neither severely impaired in ADL nor cogni-
tion. The grouping into these four categories was made
because, after comparing two models, one having ADL
and cognitive performance as independent variables, and
the other as combined variables, using AIC (Akaike’s
information criterion)[47], goodness of fit was better for
the latter (cancer: ΔAIC = -44.0; non-cancer: ΔAIC =
-43.1).
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death the following four combinations were made: both
prefer to die at home, only the patient prefers at home,
only the family prefers at home, neither prefers at home
(including those whose preferences were unknown).
SPSS version 16.0 was used for all statistical
computations.
Response rate and representativeness of the VNS sample
We examined the representativeness of the VNS. 1,020
of the 2,000 questionnaires sent to the VNS were
returned. Four of the responses were excluded due to
missing values because they had already stopped provid-
ing services, thus 1,016 VNS were analyzed (effective
response rate: 50.8%). There were no significant differ-
ences in the response rates among the prefectures.
When compared with the national data of the total
5,224 VNS, there were no significant differences in the
mean number of total patients per month (this study:
51.3; national: 52.9, Student’s t test p = 0.17). When the
VNS were dichotomized into for-profit and non-profit,
the proportion of the former was slightly lower in our
sample (this study: 10.7%; national: 13.0%, Pearson’s chi-
square test p = 0.05).
Results
After excluding 7 patients because they were under 20
years of age, and 32 patients because they lacked data
on their age, gender or cause of death, a total of 4,175
deaths were reported. Of this total, 1,664 [median
(range) per VNS = 1 (0-21)] were cancer and 2,511
[median (range) per VNS = 3 (1-33)] were non-cancer
deaths (Figure 1). The average number per VNS was
about four, which was close to the number predicted.
The median percentage of cancer to all deaths per VNS
was 33 (range = 0-100).
Table 1 shows the characteristics of the cancer and
non-cancer patients. Of the total, cancer patients com-
posed 39.9%, and non-cancer 60.1%. The average num-
ber of days from admission to hospital till death in
patients who had been hospitalized was 9.6 (SD = 8.9)
days for cancer patients, and 9.0 (SD = 9.4) days for
non-cancer patients.
Cancer and non-cancer patients differed significantly
in their characteristics. Non-cancer patients tended to
be elder, more likely to be female, more impaired in
their ADL and cognitive functions, longer duration of
care, and have clinic-based physicians. Home help ser-
vices were not extensively used among both cancer and
non-cancer patients.
Among cancer patients, although half of the patients
and 42% of the families preferred to die at home, the
proportion of which both had preferred was only one
third. When their preferences diverged, it was the
patient who had preferred to die at home. Among non-
cancer patients, both had preferred dying at home in
one quarter. When their preferences diverged, in con-
trast to cancer patients, it was the family who had pre-
ferred to die at home.
The proportion of patients whose preferences were
u n k n o w nw a s3 8 . 9 %i nt h ec a n c e rg r o u pa n d6 0 . 7 %i n
the non-cancer group. Those whose preferences were
not known had no significant differences in sex, age,
duration of VNS services and ADL. However, those with
cognitive impairment were less likely to have been able
to express their preferences, and, at the two severest
levels, three-quarter were not able to do so.
Table 2 shows the Odds ratio of dying at home based
on a bivariate logistic regression analysis of cancer and
non-cancer patients.
Factors related to dying at home in both cancer and
non-cancer patients were the following: old age, severe
impairment in ADL, both the patient and family pre-
ferred to die at home, and physicians based in clinics.
The factor related only to cancer patients were the pre-
sence of family caregiver. The factors related only to
non-cancer patients were the following: female, severe
cognitive impairment, and use of the VNS 24-hour
emergency service. Being in the longest quartile of VNS
services (126 days for cancer; 639 days for non-cancer
patients) had a significant negative effect on dying at
home for cancer patients, but a modest positive effect
for non-cancer patients.
Table 3 shows the Odds ratio and 95% confidence
interval of dying at home in the stepwise regression
model. Age and gender were not significant controlling
factors in the cancer patients, but age was significant in
the non-cancer patients. Cancer patients with severe
impairment in ADL, but not in cognition, had a signifi-
cantly higher Odds ratio for dying at home [OR (95%CI)
= 1.47 (1.07-2.03)]. Non-cancer patients with severe
impairments in both ADL and cognition [OR (95%CI) =
1.70 (1.27-2.27)] were more likely to die at home than
those with severe impairment only in ADL [OR (95%CI)
= 1.36 (1.07-1.72)].
The highest Odds ratio of dying at home in cancer
patients was the preferences of death at home both by
the patient and the family [OR (95%CI) = 57.00 (38.79-
83.76)], followed by preference of death at home only by
their families [OR (95%CI) = 20.07 (12.24-32.91)]. Pre-
ference by only the patient [OR (95%CI) = 4.69 (3.11-
7.07)] showed a lower Odds ratio of dying at home
when compared with these two groups. In non-cancer-
patients, the pattern was similar: the highest Odds ratio
of dying at home was the preferences of death at home
both by patient and the family [OR (95%CI) = 12.33
(9.51-15.99)], followed by only their families [OR (95%
CI) = 11.51 (8.56-15.99)]. Preference by only the patient
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ratio of dying at home when compared with these two
groups.
Patients served by physician-based clinics were more
likely to die at home, and the probability was greater for
cancer patients. The longest quartile group in the dura-
tion of care was less likely to die at home than the
other groups of cancer patients, but no association was
observed between the duration of care and the probabil-
ity of death at home in non-cancer patients.
The results of the model (-2 log-likelihood, degree of
freedom of chi-square statistics, and overall rate of cor-
rect classification) were (1162.9, 12, and 84.4%) in can-
cer patients, and (2370.1, 9, and 78.4%) in non-cancer
patients.
Discussion
Among patients receiving VNS services who had died,
there were more non-cancer patients than cancer
patients. This composition differs from that in Canada,
where 82.1% of the patients who died using home nur-
sing service had been diagnosed with cancer [6]. The
majority of non-cancer patients had been receiving VNS
services for more than five months, with the longest
being more than ten years, which reflects the fact that
their original purpose had been to provide long-term
care. Whether the VNS can expand their role in end-of-
life care remains to be seen but their base-line position
before the policy initiative did not provide validating
evidence. In non-cancer patients, the length of VNS ser-
vices they had received was not related to dying at
home or in hospital [12], while for cancer patients it led
to a higher likelihood of dying at hospital. This could be
due to the fact that cancer patients were being cared for
by families on the assumption that the period requiring
care would be relatively short [48].
Regarding preferences on the site of death, our study
showed that when the patient’s and the family’sp r e f e r -
ence diverged, the family’sp r e f e r e n c eh a dag r e a t e r
impact than that of the patient for both cancer and
non-cancer patients. In particular, among cancer
patients, when both preferred to die at home, it
increased the Odds ratio by more than ten times when
compared with only the patient expressing such wish.
Figure 1 Flow of subjects analysed.
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Cancer Non-cancer
1664 2511 p-value
n% n %
Cause of death
Cancer 1664 100
Old age 539 21.5
Heart disease 504 20.1
Pneumonia 481 19.2
Cerebrovascular disease 215 8.6
Others 772 30.7
Place of death
Home 701 42.1 1229 48.9 < 0.001
Hospital 963 57.9 1282 51.1
Age at death 76.3 ± 11.0 84.1 ± 10.0 < 0.001
Gender
Male 993 59.7 1199 47.7 < 0.001
Female 671 40.3 1312 52.3
ADL dependence
J (Almost independent) 220 13.2 136 5.4 < 0.001
A (Home bound) 259 15.6 335 13.3
B (Chair bound) 446 26.7 604 24.1
C (Completely bedbound) 678 40.7 1388 55.3
Cognitive impairment
Independent 946 56.9 567 22.6 < 0.001
I (Almost independent) 319 19.2 536 21.3
II (Occasional monitoring) 160 9.6 399 15.9
III (Daily care assistance) 120 7.2 416 16.6
IV (Continuous daily care assistance) 90 5.4 398 15.9
M (Special professional care) 29 1.8 195 7.8
Patient’s preference for site of death
Home 810 48.7 843 33.6 < 0.001
Hospital 207 12.4 145 5.8
Unknown 647 38.9 1523 60.7
Family’s preference for site of death
Home 700 42.1 1073 42.7 < 0.001
Hospital 634 38.1 578 23.0
Unknown 330 19.8 860 34.2
Family caregiver
None/present only at night 270 16.2 483 19.2 0.013
Present at all times 1394 83.8 2028 80.8
Type of insurance
Health insurance 1052 63.2 491 19.6 < 0.001
Long term care insurance 612 36.8 2020 80.4
Duration of VNS services
25 percentile 14 days 37 days < 0.001
50 percentile 40 days 161 days
75 percentile 126 days 639 days
Use of 24-hour VNS services
Yes 1410 84.7 2025 80.6 < 0.001
Where physician is based
Hospital 819 49.2 982 39.1 < 0.001
Clinic 812 48.8 1450 57.7
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Use of home help services
Yes 547 32.9 1413 56.3 < 0.001
ADL and cognition
Severely impaired in both ADL and cognition 94 5.7 510 20.3 < 0.001
Severely impaired in ADL, but not severely in cognition 584 35.1 878 35.0
Not severely impaired in ADL, but severely in cognition 25 1.5 81 3.2
Neither severely impaired in ADL nor in cognition 900 54.1 995 39.6
Patient’s and family’s preference for death at home
Both prefer at home 553 33.2 613 24.4 < 0.001
Only the patient prefers at home 260 15.6 230 9.2
Only the family prefers at home 147 8.9 460 18.3
Neither prefers at home 704 42.3 1208 48.1
Missing responses have not been listed so that the total does not add to 100%.
Table 2 Bivariate analysis of factors associated with dying at home
Cancer Non-cancer
Number dying at
home
% dying at
home
OR 95%CI Number dying at
home
% dying at
home
OR 95%CI
Age at death
for 10 years continuous
# ** 1.17 1.07-
1.28
*** 1.66 1.52-
1.81
Gender
Male 416 41.9 1.00 520 43.4 1.00
Female 285 42.5 1.02 0.84-
1.25
709 54.0 *** 1.53 1.31-
1.79
ADL dependence
Not severe 306 33.1 1.00 380 35.3 1.00
Severe 368 54.3 *** 2.31 1.89-
2.82
830 59.8 *** 2.64 2.24-
3.11
Cognitive impairment
Not severe 644 41.7 1.00 865 45.1 1.00
Severe 57 47.9 1.28 0.88-
1.86
364 61.4 *** 1.93 1.60-
2.33
Patient’s preference for site
of death
Home 543 67.0 *** 8.95 7.14-
11.23
581 68.9 *** 3.49 2.92-
4.16
Not home (hospital/
unknown)
158 18.5 1.00 648 38.8 1.00
Family’s preference for site
of death
Home 570 81.4 *** 27.80 21.39-
36.34
879 81.9 *** 14.08 11.57-
17.14
Not home (hospital/
unknown)
131 13.6 1.00 350 24.3 1.00
Family caregiver
None/present only at
night
71 26.3 1.00 218 45.1 1.00
Present at all times 630 45.2 *** 2.31 1.73-
3.09
1011 49.9 1.21 0.99-
1.47
Type of insurance
Health insurance 456 47.4 1.00 243 48.6 1.00
Long term care insurance 245 34.9 *** 0.59 0.49-
0.72
986 49.0 1.01 0.83-
12.4
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Duration of VNS services
Shortest quartile 207 48.5 1.00 303 50.0 1.00
2nd quartile 175 45.9 0.90 0.68-
1.19
288 47.8 0.91 0.73-
1.14
3rd quartile 198 49.3 1.03 0.78-
1.35
297 49.3 0.97 0.77-
1.21
4th quartile 119 29.4 *** 0.44 0.33-
0.58
333 55.1 † 1.22 0.98-
1.54
Use of 24-hour VNS services
Yes 592 42.0 0.96 0.73-
1.26
1008 49.8 † 1.18 0.97-
1.45
No 109 42.9 1.00 221 45.5 1.00
Where physician is based
Hospital 222 27.1 1.00 319 32.5 1.00
Clinic 465 57.3 *** 3.60 2.92-
4.43
867 59.8 *** 3.09 2.61-
3.66
Use of home help services
Yes 226 41.3 0.95 0.77-
1.17
710 50.2 1.13 0.96-
1.32
No 475 42.5 1.00 519 47.3 1.00
Missing responses have been excluded from the total in each item.
#The Odds ratio shown is for 10 years increases (i.e., the tenth power of Odds ratio per one year of age).
†p < 0.1, *p < 0.05, **p < 0.01, *** p < 0.001.
Table 3 Multiple logistic regression analysis of factors associated with dying at home
Cancer Non-cancer
OR 95%CI p-value OR 95%CI p-value
Age (for 10 years continuous)
# 1.04 0.99-1.02 0.620 1.21 1.08-1.34 0.001
Gender (ref.= male) 0.87 0.64-1.18 0.363 1.18 0.96-1.45 0.112
ADL and cognition (ref.= neither severely impaired in ADL nor in
cognition)
Severely impaired in both ADL and cognition 1.50 0.79-2.82 0.216 1.70 1.27-2.27 <0.001
Severely impaired in ADL, but not severely in cognition 1.47 1.07-2.03 0.018 1.36 1.07-1.72 0.010
Not severely impaired in ADL, but severely in cognition 1.05 0.35-3.16 0.933 0.92 0.51-1.64 0.919
Patient’s and family’s preference for death at home
(ref.= neither prefers at home)
Both prefer at home 57.00 38.79-83.76 <0.001 12.33 9.51-15.99 <0.001
Only the patient prefers at home 4.69 3.11-7.07 <0.001 2.04 1.48-2.80 <0.001
Only the family prefers at home 20.07 12.24-32.91 <0.001 11.51 8.56-15.99 <0.001
Duration of VNS services (ref.= shortest quartile)
2nd quartile 0.76 0.50-1.15 0.193 (Not selected by stepwise
procedure)
3rd quartile 0.75 0.50-1.13 0.170
4th quartile 0.32 0.21-0.49 <0.001
Where physician is based (ref.= hospital)
Clinic 2.68 1.98-3.62 <0.001 1.99 1.62-2.45 <0.001
#The Odds ratio shown is for 10 years increases (i.e., the tenth power of Odds ratio per one year of age).
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“unknown” for the patient was relatively high at 38.9%
in cancer, and very high at 60.7% in non-cancer patients.
There are three reasons why the proportion of
“unknown” w a sh i g h e rf o rt h ep a t i e n t .T h ef i r s ti st h a t ,
as has been already stated, the patient may not have any
explicit preference [44]. The second is that preferences
on death are seldom discussed in detail within the
family in Japan so that patient’s preference would not be
known by the family [26]. The third is that the patient’s
cognitive function may have declined to a level that
would make it difficult to express their preferences. In
non-cancer patients, 24% had severe dementia among
which preference could not be elucidated from three-
quarters. The future goal would be to make every effort
to elicit the preference of the patient at an early stage,
and also of the family at all times. When doing so, the
patient’s preference should be supported by relieving
family’s concerns [23,49]. Since the issue is difficult to
discuss, a professional is needed to establish relationship
with them to perform the task [50,51]. If the family
could be informed of the low possibility of an effective
treatment, they may prefer not to hospitalize [52].
There are two factors other than the preferences of
the patient and family which had lower, but still statisti-
c a l l ys i g n i f i c a n te f f e c t s ,o nt h es i t eo fd e a t h .F i r s t ,
patients who had severe impairment in ADL but not in
cognition, tended to die at home in both groups
[5,9,21]. Among non-cancer patients, the Odds ratio was
higher for those who had severe impairment in both.
Thus, appropriate protocols for the families and health
care professionals to make end-of-life decisions should
be designed for these patients [12,13,17]. Such protocols
would be particularly needed in Japan because the
patient is less likely to have communicated his or her
preferences to family members [26].
Second is where the physician is based: in clinics or
hospitals. Being clinic-based increased the possibility of
dying at home. The choice of the physician will depend
on their willingness to make home visits in the commu-
nity [9,14]. In Japan, although 89% of the home visits
were made by clinic-based physicians, 11% were made
by hospital-based physicians [53]. This percentage may
be higher for complex cases, as evidenced by the fact
that hospital-based physicians comprised 49.2% of the
total in cancer, which was higher than 39.1% in non-
cancer. Whether the physician being hospital-based is
related to the patient dying at home after controlling for
medical complexity must be explored in the future.
Limitations
There were several limitations in our study. First, the
subjects were limited to patients served by VNS who had
died either at home or hospital. The rest may have
received care only from physicians or have died without
receiving any services from health care professionals.
Thus, our subjects were composed of those who may
have been more conscious of their health care needs, or
who are attended by physicians more aware of the bene-
fits of VNS services. Further studies should be made of
those dying at home who had not been receiving VNS
services. Among those who had died in hospital, we do
not know how representative our sample was because
there have been no studies on the proportion of patients
who had been discharged, received VNS services, and
then subsequently readmitted. There is a general impres-
sion that this proportion is not high [54] implying that
our sample would have unique characteristics which
should be investigated in the future. The sample excluded
those who may have died in hospital after four weeks of
terminating VNS services. However, of those who had
died within four weeks, virtually all would have been cap-
tured because the VNS must give reports on the patients’
status to the physician every calendar month in order to
receive their orders for the next month.
Second, since this study was designed as a retrospec-
tive, cross-sectional survey based on the VNS records,
there are questions on reliability. Also, items were lim-
ited to those that could be uniformly found in the
records. Data such as the patient’s symptoms [55] and
the family’s health status [6] were not collected. Another
issue is whether the patient’s condition recorded reflects
that when he or she died. However, there were no dif-
ferences in the period from the date of the condition
recorded till the date of death between those who had
died at home, and those who had died in hospital: for
the former, it was 14.1 days for cancer patients, and
15.1 days for non-cancer patients; for the latter, it was
23.6 days for cancer patients, and 23.7 days for non-can-
cer patients. Although changes in day to day condition
are not recorded, since the greater majority of our sub-
jects are over 70 years old, the extent of change in the
last one month of life might not be extensive [56]. To
clarify these points, a prospective study or an in-depth
interview survey of a small number of patients and their
families should be made in the future.
The third issue is the response rate. Although half is
not necessary low for surveys made in Japan [26], we do
not know about the patients who had received services
from VNS that had not responded. 88% of the VNS that
have responded replied that “they would like to support
dying at home in their community”, implying that the
patients had received services from VNS more active in
end-of-life care.
Conclusions
Among those who had received end-of-life care from
VNS, the proportion of non-cancer patients was greater
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Page 9 of 11than cancer patients. Non-cancer patients tended to be
older and more impaired, and had a longer duration of
care. In both groups, the greatest likelihood of dying at
home was when both the patient and the family pre-
ferred, followed by only the family preferred, and then by
when only the patient preferred. Health care profes-
sionals should provide opportunities for patient and the
family to voice their preference on where they would
wish to die, following which they should then take appro-
priate measures to achieve this outcome where possible.
Additional material
Additional file 1: Questionnaire
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